The groundbreaking therapy of the medication represents a exciting advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide678209.win-blog.com/23334224/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment